CONNECT WITH US
HealthTech

HealthTech

Quest Diagnostics hit by cyberattack

MedTech Dive logo

Published on

Add as a preferred source on Google
Quest Diagnostics hit by cyberattack

Quest Diagnostics is the latest medtech company to disclose that it was hit by a cyberattack.

The testing services company identified unauthorized access to its Quanum Lab Services Manager system on Wednesday, according to a filing with the Securities and Exchange Commission. Quest’s Quanum LSM system is used by certain clients to place test orders as well as to receive and look up results. Quest paused access to the system upon discovering the incident.

While Quest is still determining the full scope of the attack, it believes that an unauthorized party accessed certain patient records. Quest, in the filing, did not detail what patient records were accessed or how many records were involved.

In an update posted to its website, Quest said that patient health information or patient identifiable information was part of the unauthorized access, although the company is still determining specific data affected.

Quest said the incident has not materially disrupted its operations or ability to serve patients.“Core business operations are not impacted and remain up and running,” Quest said on its website.

The company has notified federal law enforcement authorities and engaged external cybersecurity experts to assist in the investigation and the response.

Quest did not provide additional information Thursday during a third-quarter earnings call.

Cyberattacks have been an ongoing problem for the medical device industry for much of the year. Companies like Stryker, Boston Scientific, Medtronic and Abbott have all disclosed cyberattacks, as have Intuitive, iRhythm and AdaptHealth.

While some attacks have involved patient data exposure, some have had significant impacts on companies’ businesses.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.